Production is the number everything else rides on, and open chair-time you lose today can't be re-sold tomorrow. A slow morning becomes a slow week becomes a missed month.
Front-load the schedule: fill tomorrow's gaps, pull cancellations forward, and chase accepted-but-unscheduled treatment to start closing the budget gap before month-end.
New patients fuel ~40% of doctor production and feed tomorrow's hygiene and restorative chairs. A soft number now shows up as empty chairs 6–12 months out.
Pre-book the next hygiene visit before every checkout to plug attrition first, then drive new-patient phone conversion and reactivation — and track it weekly.
Every churned appointment is an open chair you can't recover that day. Because this is a profit lever, cutting churn drops straight to EBITDA — it protects margin, not just top-line.
Tighten your 48h/24h confirmation cadence, rebook any cancellation before the patient leaves the call, and keep a same-day waitlist to refill freed chairs.
Patients falling off the schedule front-desk side. Sit with the team on how appts get cancelled/rescheduled/dropped and tighten that process.
Tracking behind budget. Walk the schedule and the production plan and close the gap where the day-to-day numbers slip.
Same gap as McVea. Get the team back on plan against budget and find the production left on the table each day.
Admin Appointment Churn is your one shared gap — broken in all 3 of 3 offices and a profit lever worth $492,892. Don't run three separate fixes. Pull the front-desk teams from all three into one training on how appointments get cancelled, rescheduled and dropped, and standardize the process once across the region.
Hygiene Production / Visit is also region-wide and a good second topic for the same session — but churn is the bigger money and the one to lead with.
None of your 3 offices has acted yet — all three have 3 open directives, zero measured, zero moved. The loop is stalled on action, not results. First job: get these teams to do what was already asked.
+4-week results are still accruing — too early to judge whether directives worked. Right now there's nothing to judge because nobody has started.